Clinical Trial Details

NCT ID: NCT01797224
Date Last Changed: March 22, 2017

Overview

Research Study Summary

A clinical trial seeking patients for a research study for the treatment of Crohn's Disease or Rheumatoid Arthritis

Research Study Title

Cimzia (Certolizumab Pegol) Pregnancy Exposure Registry: OTIS Autoimmune Diseases in Pregnancy Project

Purpose

The purpose of the OTIS Autoimmune Diseases in Pregnancy Study is to monitor planned and unplanned pregnancies exposed to certain medications, to evaluate the possible teratogenic effect of these medications and to follow live born infants for five years after birth. With respect to fetal outcome, it is important to evaluate the spectrum of outcomes that may be relevant to a medication exposure during pregnancy, and these include both easily recognizable defects which are visible at birth, as well as more subtle or delayed defects that may not be readily identifiable without special expertise and observation beyond the newborn period.

To Learn more

Recruitment Details

Gender
Female
Age
N/A
Overall Status
Recruiting
Lead Sponsor
University of California, San Diego
Duration
93 Months
Facility Type
N/A
Compensation

Eligibility

Female ages up to N/A

Inclusion Criteria:

  • Currently pregnant

Site Locations (1)

Country State City Zip Facility and Contact
United States California San Diego 92093 University of California, San Diego
Diana Johnson, MS
877-311-8972
d4johnson@ucsd.edu

Christina Chambers, MPH, PhD
Principal Investigator

Contact

Diana Johnson, MS
877-311-8972
E-mail:

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.